Defining the risk of involvement for each neck nodal level in patients with early T-stage node-positive oropharyngeal carcinoma.

Defining the risk of involvement for each neck nodal level in patients with early T-stage node-positive oropharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q45941421
Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy.Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.Characterization of the oropharynx: anatomy, histology, immunology, squamous cell carcinoma and surgical resection.Prophylactic dissection of level V in primary mucosal SCC in the clinically N positive neck: A systematic review.HPV-related oropharyngeal carcinoma with Overt Level II and/or III metastases at presentation: The risk of subclinical disease in ipsilateral levels IB, IV and V.Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control.An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result.Temporal characterization of lymphatic metastasis in an orthotopic mouse model of oral cancer.Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance.Role of positron emission tomography in the treatment of occult disease in head-and-neck cancer: a modeling approach.Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.Neck metastases in oropharyngeal cancer: Necessity and extent of bilateral treatment.Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.Feasibility and relevance of level I substation node counts in oropharyngeal carcinoma.
P2860

Defining the risk of involvement for each neck nodal level in patients with early T-stage node-positive oropharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q45941421
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Defining the risk of involveme ...... itive oropharyngeal carcinoma.
@en
Defining the risk of involveme ...... itive oropharyngeal carcinoma.
@nl
type
label
Defining the risk of involveme ...... itive oropharyngeal carcinoma.
@en
Defining the risk of involveme ...... itive oropharyngeal carcinoma.
@nl
prefLabel
Defining the risk of involveme ...... itive oropharyngeal carcinoma.
@en
Defining the risk of involveme ...... itive oropharyngeal carcinoma.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Defining the risk of involveme ...... itive oropharyngeal carcinoma.
@en
P2093
P304
P31
P356
10.1016/J.IJROBP.2008.10.018
P407
P433
P478
P577
P698